General News

Regeneron’s COVID-19 treatment gets emergency approval by FDA

Regeneron's COVID-19 treatment gets emergency approval by FDA

The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Regeneron’s drug is a combination of two monoclonal antibodies. A similar drug developed by Eli Lilly & Co. gained FDA emergency clearance earlier this month.

However the Regeneron treatment may not be immediately widely available: the company has said it will have just 80,000 doses by the end of November.

About the author

mm

Devon Bell

Devon is a fitness enthusiast who loves playing Golf in his free time. He keeps in touch with the Golf events happening all around the world and jots down fine news pieces for the website.

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *